Year |
Citation |
Score |
2015 |
Vaughan AE, Brumwell AN, Xi Y, Gotts JE, Brownfield DG, Treutlein B, Tan K, Tan V, Liu FC, Looney MR, Matthay MA, Rock JR, Chapman HA. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature. 517: 621-5. PMID 25533958 DOI: 10.1038/nature14112 |
0.96 |
|
2014 |
Liu KD, Wilson JG, Zhuo H, Caballero L, McMillan ML, Fang X, Cosgrove K, Calfee CS, Lee JW, Kangelaris KN, Gotts JE, Rogers AJ, Levitt JE, Wiener-Kronish JP, Delucchi KL, et al. Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. Annals of Intensive Care. 4: 22. PMID 25593740 DOI: 10.1186/s13613-014-0022-z |
0.96 |
|
2014 |
Gotts JE, Matthay MA. Endogenous and exogenous cell-based pathways for recovery from acute respiratory distress syndrome. Clinics in Chest Medicine. 35: 797-809. PMID 25453426 DOI: 10.1016/j.ccm.2014.08.015 |
0.96 |
|
2014 |
Gotts JE, Abbott J, Matthay MA. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy. American Journal of Physiology. Lung Cellular and Molecular Physiology. 307: L395-406. PMID 25038188 DOI: 10.1152/ajplung.00110.2014 |
0.96 |
|
2014 |
Gotts JE, Matthay MA. Treating ARDS: new hope for a tough problem. The Lancet. Respiratory Medicine. 2: 84-5. PMID 24503258 DOI: 10.1016/S2213-2600(13)70285-6 |
0.96 |
|
2013 |
Gotts JE, Matthay MA. Cell therapy for lung disease: a step forward. Chest. 143: 1525-7. PMID 23732575 DOI: 10.1378/chest.12-2993 |
0.96 |
|
2012 |
Gotts JE, Matthay MA. Mesenchymal stem cells and the stem cell niche: a new chapter. American Journal of Physiology. Lung Cellular and Molecular Physiology. 302: L1147-9. PMID 22505672 DOI: 10.1152/ajplung.00122.2012 |
0.96 |
|
2011 |
Gotts JE, Matthay MA. Mesenchymal stem cells and acute lung injury. Critical Care Clinics. 27: 719-33. PMID 21742225 DOI: 10.1016/j.ccc.2011.04.004 |
0.96 |
|
2005 |
Gotts JE, Chesselet MF. Mechanisms of subventricular zone expansion after focal cortical ischemic injury. The Journal of Comparative Neurology. 488: 201-14. PMID 15924343 DOI: 10.1002/cne.20609 |
0.96 |
|
2005 |
Gotts JE, Chesselet MF. Vascular changes in the subventricular zone after distal cortical lesions. Experimental Neurology. 194: 139-50. PMID 15899251 DOI: 10.1016/j.expneurol.2005.02.001 |
0.96 |
|
2005 |
Gotts JE, Chesselet MF. Migration and fate of newly born cells after focal cortical ischemia in adult rats. Journal of Neuroscience Research. 80: 160-71. PMID 15751027 DOI: 10.1002/jnr.20434 |
0.96 |
|
2002 |
Liang Q, Gotts J, Satyamurthy N, Barrio J, Phelps ME, Gambhir SS, Herschman HR. Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message by positron emission tomography, following gene transfer with adenovirus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 73-82. PMID 12095306 DOI: 10.1006/mthe.2002.0626 |
0.96 |
|
2000 |
Gotts JE, Press C, Leasure JL, Schallert T. Focal brain injury, FGF-2 and the adverse effects of excessive motor demand on cortical and nigral degeneration: marked protection by delayed intermittent exposure to halothane. Journal of Neurotrauma. 17: 1067-77. PMID 11101209 |
0.96 |
|
1998 |
Humm JL, Kozlowski DA, James DC, Gotts JE, Schallert T. Use-dependent exacerbation of brain damage occurs during an early post-lesion vulnerable period. Brain Research. 783: 286-92. PMID 9507166 DOI: 10.1016/S0006-8993(97)01356-5 |
0.96 |
|
1997 |
Kawamata T, Dietrich WD, Schallert T, Gotts JE, Cocke RR, Benowitz LI, Finklestein SP. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proceedings of the National Academy of Sciences of the United States of America. 94: 8179-84. PMID 9223335 DOI: 10.1073/pnas.94.15.8179 |
0.96 |
|
Show low-probability matches. |